To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

OPDP Bulletins

  • OPDP BULLETINS MARCH 29-APRIL 4, 2017

    OPDP Notice.17046 posted March 31, 2017, e-Formulary Outage Notice OPDP Notice. 17048 posted April 03, 2017 Prescription Forgery Alert OPDP Notice.17046 posted March 31, 2017, e-Formulary Outage Notice e-FORMULARY OUTAGE NOTIFICATION TO …

    September 03, 2013
  • OPDP BULLETINS MARCH 22-28, 2017

    OPDP Notice No. 17043 posted March 22, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – March 2017 OPDP Notice No.17044 ODB Program Payment Dates 2017-18 OPDP Notice No. 17045 - Monitored Drugs List (MDL) Update OPDP Notice No. 17043 …

    September 03, 2013
  • OPDP BULLETINS MARCH 15-21, 2017

    OPDP Notice No. 17037 posted March 15, 2017 Prescription Forgery Alert OPDP Notice No. 17038 posted March 16, 2017 Prescription Forgery Alert OPDP Notice No. 17039 posted March 16, 2017 Notice from the Executive Officer: Pan-Canadian Select …

    September 03, 2013
  • OPDP BULLETINS MARCH 1-7, 2017

    OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17034 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert Prescription Forgery Alert …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 22-28, 2017

    OPDP Notice No. 17029 posted February 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – February 2017 OPDP Notice No. 17030 posted February 21, 2017 Notice from the Executive Officer: Funding of Hepatitis C drug products under the …

    September 03, 2013
  • OPDP BULLETINS FEBRUARY 1-7, 2017

    OPDP Notice No. 17019 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17020 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17021 posted February 03, 2017 Prescription Forgery Alert OPDP Notice No. 17022 …

    September 03, 2013
  • OPDP BULLETINS JANUARY 11-17, 2017

    OPDP Notice No. 17007 posted January 11, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program OPDP Notice No. 17008 posted January 13, 2017 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS …

    September 03, 2013
  • OPDP BULLETINS JANUARY 4-10, 2017

    OPDP Notice No. 17003 posted January 04, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program Ontario Public Drug Programs, Ministry of Health and Long-Term Care Reminder regarding …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 29-JANUARY 3, 2016

    OPDP Notice No. 17001 posted January 03, 2017 CPSO Notice OPDP Notice No. 17002 posted January 03, 2017 CPSO Notice OPDP Notice No. 17001 posted January 03, 2017 CPSO Notice Please be advised of the following public notices issued by the …

    September 03, 2013
  • OPDP BULLETINS DECEMBER 21-28, 2016

    OPDP Notice No. 16164 posted December 21, 2016 Notice from the Executive Officer: Funding of Grastofil (filgrastim) under the Ontario Drug Benefit program OPDP Notice No. 16164A posted December 21, 2016 RE: Notice from the Executive Officer: …

    September 03, 2013
Back to top